Clinical Trial Update: A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the PET/CT radiotracer [18F]FluorThanatrace for imaging breast cancer; currently listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 18F-FluorThanatrace

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING